The advanced development of medical technology has accelerated in recent years, with devices being continuously manufactured for healthcare professionals as well as consumers at home. From wellbeing ...
MIAMI, June 10, 2026--(BUSINESS WIRE)--DermaSensor, a health technology company transforming skin cancer detection with AI-powered technology, today announced it has received Class IIb CE Mark for the ...
Innovative Skin Cancer Detection Device Transforming Patient Care in Physician Offices Throughout U.S. The FDA Cleared, CE Marked DermaSensor device enables physicians to non-invasively provide ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The device makes it possible for ...
Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.
The Food and Drug Administration (FDA) has approved DermaSensor's groundbreaking AI-powered medical device, marking a pivotal moment as the first artificial intelligence-driven tool designed to assist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results